Fierce Biotech
Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $1.9B
With three Big Pharma collaborations already under its belt, Flagship Pioneering spinout Repertoire Immune Medicines has picked up another—and its biggest yet—in a further validation of the company | With three Big Pharma collaborations already under its belt, Flagship Pioneering spinout Repertoire…
